Outputs (118)

Correction to: same-day discharge after elective percutaneous coronary intervention for chronic total occlusion in the UK. (2024)
Journal Article
Taxiarchi, P., Kontopantelis, E., Kinnaird, T., Curzen, N., Ahmed, J., Zaman, A., Ludman, P., Shoaib, A., Martin, G. P., & Mamas, M. A. (in press). Correction to: same-day discharge after elective percutaneous coronary intervention for chronic total occlusion in the UK. Journal of Invasive Cardiology, https://doi.org/10.25270/jic/21.00036.cx

This corrects the article doi: 10.25270/jic/21.00036.

Outcomes of 1.3 million patients undergoing percutaneous coronary intervention according to the presence of cancer and atrial fibrillation: a retrospective study. (2024)
Journal Article
Istanbuly, S., Matetić, A., Bang, V., Sharma, K., Golwala, H., Kheiri, B., Osman, M., Swamy, P., Bharadwaj, A., & Mamas, M. A. (2024). Outcomes of 1.3 million patients undergoing percutaneous coronary intervention according to the presence of cancer and atrial fibrillation: a retrospective study. Croatian Medical Journal, 65(5), 405-416

To evaluate outcomes after percutaneous coronary intervention (PCI) in patients with cancer and atrial fibrillation (AF). Data of all adult discharges undergoing PCI between October 2015 and December 2018 were obtained from the National Inpatient Sam... Read More about Outcomes of 1.3 million patients undergoing percutaneous coronary intervention according to the presence of cancer and atrial fibrillation: a retrospective study..

Immediate Versus Staged Complete Revascularization for Patients With ST‐Segment–Elevation Myocardial Infarction and Multivessel Disease: A Network Meta‐Analysis of Randomized Trials (2024)
Journal Article
Elbadawi, A., Hamed, M., Gad, M., Elseidy, S. A., Barghout, M., Jneid, H., Mamas, M. A., Alfonso, F., & Elgendy, I. Y. (in press). Immediate Versus Staged Complete Revascularization for Patients With ST‐Segment–Elevation Myocardial Infarction and Multivessel Disease: A Network Meta‐Analysis of Randomized Trials. Journal of the American Heart Association, 13(21), https://doi.org/10.1161/jaha.124.035535

Background The comparative outcomes with immediate, staged in‐hospital, and staged out‐of‐hospital complete revascularization for patients with ST‐segment–elevation myocardial infarction and multivessel disease remain unclear. Methods and Results An... Read More about Immediate Versus Staged Complete Revascularization for Patients With ST‐Segment–Elevation Myocardial Infarction and Multivessel Disease: A Network Meta‐Analysis of Randomized Trials.

TCT-59 Optimal Versus Sub-Optimal Intravascular Imaging-guided Percutaneous Coronary Intervention: A Meta-Analysis (2024)
Presentation / Conference Contribution
Hamed, M., Elseidy, S., Ahmed, A., Gabr, E., Kahan, J., & Mamas, M. TCT-59 Optimal Versus Sub-Optimal Intravascular Imaging-guided Percutaneous Coronary Intervention: A Meta-Analysis. Presented at Thirty-Sixth Annual Symposium Transcatheter Cardiovascular Therapeutics (TCT)–Abstracts, Walter E. Washington Convention Center, Washington, DC, USA

Background
Intravascular imaging–guided percutaneous coronary intervention (PCI) has shown promising results. Our study aimed to compare the outcomes of optimal vs suboptimal intravascular imaging–guided PCI.

Addressing disparities in the long-term mortality of non-ST segment myocardial infarction (NSTEMI) patients according to the presence of diabetes mellitus: a nationwide cohort study (2024)
Journal Article
Cole, A., Weight, N., Mishra, S., Grapsa, J., Rutter, M., Siudak, Z., Moledina, S., Khunti, K., & Mamas, M. (2024). Addressing disparities in the long-term mortality of non-ST segment myocardial infarction (NSTEMI) patients according to the presence of diabetes mellitus: a nationwide cohort study. European Heart Journal, 45(Supplement_1), https://doi.org/10.1093/eurheartj/ehae666.1533

Background Diabetes mellitus (DM) is an important risk factor for non−ST segment elevation myocardial infarction (NSTEMI). How DM is related to management and longer-term clinical outcomes in contemporary NSTEMI cohorts is not well described. Methods... Read More about Addressing disparities in the long-term mortality of non-ST segment myocardial infarction (NSTEMI) patients according to the presence of diabetes mellitus: a nationwide cohort study.

Hemodynamic and clinical outcomes with balloon-expandable valves versus self-expanding valves in patients with small aortic annulus undergoing transcatheter aortic valve replacement: A meta-analysis of randomized controlled trials and propensity score matched studies (2024)
Journal Article
Ahmed, M., Ahsan, A., Tabassum, S., Tariq, I., Zulfiqar, E., Raja, M. F., Mahmood, A., Ahmed, R., Shahid, F., Gardezi, S. K. M., Alam, M., Bagur, R., & Mamas, M. A. (2024). Hemodynamic and clinical outcomes with balloon-expandable valves versus self-expanding valves in patients with small aortic annulus undergoing transcatheter aortic valve replacement: A meta-analysis of randomized controlled trials and propensity score matched studies. IJC Heart & Vasculature, 55, Article 101542. https://doi.org/10.1016/j.ijcha.2024.101542

Transcatheter aortic valve replacement (TAVR) is considered more effective than surgical aortic valve implantation for patients with a small aortic annulus (SAA), however, the comparative efficacy of different transcatheter heart valves (THVs) remain... Read More about Hemodynamic and clinical outcomes with balloon-expandable valves versus self-expanding valves in patients with small aortic annulus undergoing transcatheter aortic valve replacement: A meta-analysis of randomized controlled trials and propensity score matched studies.

Myocardial infarction risk across cancer subtypes - nationwide registry study (2024)
Presentation / Conference Contribution
Shanmuganathan, J., Jacobsen, P. A. J., Schou, M. S., Torp Pedersen, C. T. P., Poulsen, L., Polcwiartek, C. B. P., Godtfredsen, S. J. G., Gislason, G. G., Koeber, L. K., Nielsen, D. N., El-Galaly, T. E. C., Sogaard, P. S., Mamas, M. A. M., Freeman, P. F., & Kragholm, K. K. Myocardial infarction risk across cancer subtypes - nationwide registry study

Background Progress in cancer treatments have significantly improved patient outcomes, leading to increased survival rates. However, patients with cancer continue to have higher rates of cardiovascular events an area that has traditionally not receiv... Read More about Myocardial infarction risk across cancer subtypes - nationwide registry study.

Insights into the reporting of major adverse cardiovascular events in coronary artery disease trials (2024)
Presentation / Conference Contribution
Lee, E., Tan, B., Chin, Y. H., Chan, Y. H., Ong, J., Goh, R. S. J., Chong, B., Anand, V. V., Kong, G., Wang, J. W., Muthiah, M. D., Loh, P. H., Chan, M. Y., Chew, N. W. S., & Mamas, M. A. Insights into the reporting of major adverse cardiovascular events in coronary artery disease trials. Presented at ESC Congress 2024 30 August – 02 September London, UK Abstract Supplement

Background and Purpose Major adverse cardiovascular event (MACE) is one of the most used composite outcomes in coronary artery disease (CAD) trials, though its lack of a standardised definition has led to ambiguity and challenges in its interpretatio... Read More about Insights into the reporting of major adverse cardiovascular events in coronary artery disease trials.

Ischemic and bleeding risk after ST-segment elevated myocardial infarction in patients with active cancer (2024)
Presentation / Conference Contribution
Dafaalla, M., Costa, F., Jia, H., Wijeysundera, H., Rashid, M., Graham, M., Wojakowski, W., Chieffo, A., Mintz, G., & Mamas, M. Ischemic and bleeding risk after ST-segment elevated myocardial infarction in patients with active cancer. Presented at ESC Congress 2024 30 August – 02 September London, UK Abstract Supplement

Background Treatment of patients with cancer presenting with ST-elevation myocardial infarction (STEMI) is complex given the increased risk of both thrombotic and major bleeding complications. We evaluated the risk of major bleeding and re-infarction... Read More about Ischemic and bleeding risk after ST-segment elevated myocardial infarction in patients with active cancer.

Association of lifes essential 8 and mortality among adults with and without CVD (2024)
Presentation / Conference Contribution
Kobo, O., Kaur, G., Gulati, M., & Mamas, M. Association of lifes essential 8 and mortality among adults with and without CVD. Presented at ESC Congress 2024 30 August – 02 September London, UK Abstract Supplement

Background Differences in the American Heart Association’s Life’s Essential 8 (LE8) score and its association with mortality based on the presence of clinically prevalent cardiovascular disease (CVD) has not been assessed previously. Methods Data fro... Read More about Association of lifes essential 8 and mortality among adults with and without CVD.